|Videos|August 2, 2021
Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements
Author(s)Parexel
Advertisement
A roundtable discussing the opportunities that synthetic control arms offer for patients and product developers, and how to overcome potential barriers with the use of this burgeoning clinical trial model.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Novavax's Strategy Across Commercial, R&D, and Partnerships
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
FDA Approves Skinvive by Juvéderm for Improvement of Neck Appearance
5